Premium
Centessa Pharmaceuticals PLC (CNTA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Medicxi Ventures (UK) LLP | Institution | 19 963 157 | 12,90% | US$ 794,53M | 2026-03-31 |
| Avoro Capital Advisors LLC | Institution | 11 430 455 | 7,39% | US$ 454,93M | 2026-03-31 |
| Medicxi Secondary I, LP | Institution | 11 197 303 | 7,24% | US$ 445,65M | 2025-04-24 |
| Index Ventures SA | Institution | 9 961 789 | 6,44% | US$ 396,48M | 2026-03-31 |
| Index Ventures VI | Institution | 9 812 368 | 6,34% | US$ 390,53M | 2025-04-24 |
| Adage Capital Management, L.P. | Institution | 8 925 010 | 5,77% | US$ 355,22M | 2026-03-31 |
| Adage Capital Partners, L.P. | Institution | 8 925 010 | 5,77% | US$ 355,22M | 2026-03-31 |
| Pentwater Capital Management LP | Institution | 8 170 000 | 5,28% | US$ 325,17M | 2026-03-31 |
| FMR LLC | Institution | 6 852 047 | 4,43% | US$ 272,71M | 2026-03-31 |
| EcoR1 Capital, LLC | Institution | 6 000 000 | 3,88% | US$ 238,80M | 2026-03-31 |
| Perceptive Advisors LLC | Institution | 5 258 903 | 3,40% | US$ 209,30M | 2026-03-31 |
| Capital Research and Management Company | Institution | 4 832 548 | 3,12% | US$ 192,34M | 2026-03-31 |
| Farallon Capital Management, L.L.C. | Institution | 4 809 000 | 3,11% | US$ 191,40M | 2026-03-31 |
| Medicxi Ventures 1 | Institution | 4 454 196 | 2,88% | US$ 177,28M | 2025-04-24 |
| TCG Crossover Management, LLC | Institution | 4 286 480 | 2,77% | US$ 170,60M | 2026-03-31 |
| Morgan Stanley | Institution | 4 268 353 | 2,76% | US$ 169,88M | 2026-03-31 |
| Medicxi Growth I LP | Institution | 4 030 496 | 2,60% | US$ 160,41M | 2025-04-24 |
| Paradigm Biocapital Advisors LP | Institution | 3 574 048 | 2,31% | US$ 142,25M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 3 492 977 | 2,26% | US$ 139,02M | 2026-03-31 |
| Deep Track Capital, LP | Institution | 3 158 041 | 2,04% | US$ 125,69M | 2026-03-31 |
| Ecor1 Capital Fund Qualified, L.P. | Institution | 3 033 334 | 1,96% | US$ 120,73M | 2024-09-30 |
| Logos Global Management, L.P. | Institution | 2 125 000 | 1,37% | US$ 84,58M | 2026-03-31 |
| RTW Investments, LP | Institution | 2 054 175 | 1,33% | US$ 81,76M | 2026-03-31 |
| Federated Hermes, Inc. | Institution | 2 049 439 | 1,32% | US$ 81,57M | 2026-03-31 |
| Braidwell LP | Institution | 1 986 768 | 1,28% | US$ 79,07M | 2026-03-31 |
| Bank of America Corporation | Institution | 1 924 392 | 1,24% | US$ 76,59M | 2026-03-31 |
| Maverick Capital, Ltd. | Institution | 1 854 488 | 1,20% | US$ 73,81M | 2026-03-31 |
| First Light Asset Management, LLC | Institution | 1 560 991 | 1,01% | US$ 62,13M | 2026-03-31 |
| Affinity Asset Advisors, LLC | Institution | 1 400 000 | 0,90% | US$ 55,72M | 2026-03-31 |
| Foresite Capital Management, LLC | Institution | 1 364 019 | 0,88% | US$ 54,29M | 2026-03-31 |
| General Atlantic Service Company, L.P. | Institution | 1 354 830 | 0,88% | US$ 53,92M | 2026-03-31 |
| Artal Group S.A. | Institution | 1 053 464 | 0,68% | US$ 41,93M | 2026-03-31 |
| Cormorant Asset Management, LP | Institution | 1 050 000 | 0,68% | US$ 41,79M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 1 040 745 | 0,67% | US$ 41,42M | 2026-03-31 |
| Alpine Associates Management Inc. | Institution | 865 500 | 0,56% | US$ 34,45M | 2026-03-31 |
| Woodline Partners LP | Institution | 859 105 | 0,56% | US$ 34,19M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 852 828 | 0,55% | US$ 33,94M | 2026-03-31 |
| Octagon Capital Advisors LP | Institution | 750 000 | 0,48% | US$ 29,85M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
